The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Book Review
PreviousPrevious
Volume 330:1164 April 21, 1994 Number 16
NextNext

Chronic Lymphocytic Leukemia: Scientific Advances and Clinical Developments

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
Edited by Bruce D. Cheson. 424 pp., illustrated. New York, Marcel Dekker, 1993. $99.75. ISBN 0-8247-8736-6.

Chronic lymphocytic leukemia is the most common hematologic cancer in the United States. There has been a need for a comprehensive review of the disease, especially in the light of recent advances in the understanding of its pathophysiology and treatment. This important book fills this need.

The book is divided into 18 chapters, all by different authors. The first 11 chapters discuss the immunology and molecular biology of chronic lymphocytic leukemia and the physiologic bases of treatment and drug resistance. A chapter on purine analogues is a thorough review of the mechanisms of this important class of antimetabolites. A superb, . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.